DNA methylation-based biomarkers from circulating tumour DNA
Topic Status Complete
DNA methylation-based biomarkers from circulating tumour DNA for the diagnosis of pancreatic cancer
Specialities: Cancer
Summary
Health Technology Wales researchers searched for evidence on the clinical and cost effectiveness of DNA methylation biomarkers from circulating tumour DNA derived from blood draws to diagnose pancreatic cancer.
Based on the evidence identified, HTW’s Assessment Group concluded not to progress this topic to evidence appraisal.
Topic Exploration Report
TER637 01.2026
Health Technology Wales Partners
